undefined cover
undefined cover
AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies cover
AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies cover
PATH News Network Daily Edition

AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies

AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies

03min |18/08/2025
Play
undefined cover
undefined cover
AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies cover
AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies cover
PATH News Network Daily Edition

AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies

AI Treatment Plans at Cedars-Sinai; Understanding Pancreatic Needle Biopsies

03min |18/08/2025
Play

Transcription

  • Nancy Johnson

    AI tools are now treating patients around the clock. Where do physicians fit in? This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, August 18th. Here are the latest headlines. A medical center in LA is using AI to deliver 24-7 care to patients through an app. Cedars-Sinai found that AI treatment plan recommendations were considered optimal 77% of the time compared to 67% for plans by physicians. The CAP's Dr. Hung Luu says while AI shows promise, human physician expertise must remain central. especially when patient cases require clinical judgment beyond guidelines. He emphasizes that pathologists should train AI models directly to ensure treatment plans are always evidence-based. Read the full article in the show notes. In other news, pathologists can stay ahead in the rapidly evolving DEIA landscape with a new course at CAP25 next month in Orlando. This CME accredited session. will cover the latest regulations and describe current strategies to advance equity and improve patient care. Attendees will learn how shifting diversity, equity, inclusion, and accessibility priorities affect lab operations. Dr. Kisha Mitchell Richards, who chairs the CAP's DEI committee, will lead the session. Go to the show notes to register for CAP25. Also at CAP25, pathologists can sharpen their skills with a specialized course on pancreatic fine needle biopsies. Led by the CAP's Dr. Min Cui and Dr. Wei Xin, the session will tackle the diagnostic challenges presented by these tests. Through real-life cases, the course will explore both common and rare pancreatic lesions, including epithelial and metastatic tumors. It's designed for pathologists at all levels who interpret these complex biopsy samples. And finally, another course at the annual meeting will help pathologists better understand both common cervical glandular lesions as well as newly recognized ones. Led by Dr. Krisztina Hanley and Dr. Gulisa Turashvilli from the CAP, this session covers how to spot these lesions and what to look for in biopsy and excision samples. Case-based examples will offer practical guidance. The link to register for both of these scientific courses offering CME credits is in the show notes. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in our CAP newsletters every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern. Subscribe to this show on Apple, Spotify, or your favorite podcast platform. I'm Nancy Johnson. Have a great day.

Transcription

  • Nancy Johnson

    AI tools are now treating patients around the clock. Where do physicians fit in? This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, August 18th. Here are the latest headlines. A medical center in LA is using AI to deliver 24-7 care to patients through an app. Cedars-Sinai found that AI treatment plan recommendations were considered optimal 77% of the time compared to 67% for plans by physicians. The CAP's Dr. Hung Luu says while AI shows promise, human physician expertise must remain central. especially when patient cases require clinical judgment beyond guidelines. He emphasizes that pathologists should train AI models directly to ensure treatment plans are always evidence-based. Read the full article in the show notes. In other news, pathologists can stay ahead in the rapidly evolving DEIA landscape with a new course at CAP25 next month in Orlando. This CME accredited session. will cover the latest regulations and describe current strategies to advance equity and improve patient care. Attendees will learn how shifting diversity, equity, inclusion, and accessibility priorities affect lab operations. Dr. Kisha Mitchell Richards, who chairs the CAP's DEI committee, will lead the session. Go to the show notes to register for CAP25. Also at CAP25, pathologists can sharpen their skills with a specialized course on pancreatic fine needle biopsies. Led by the CAP's Dr. Min Cui and Dr. Wei Xin, the session will tackle the diagnostic challenges presented by these tests. Through real-life cases, the course will explore both common and rare pancreatic lesions, including epithelial and metastatic tumors. It's designed for pathologists at all levels who interpret these complex biopsy samples. And finally, another course at the annual meeting will help pathologists better understand both common cervical glandular lesions as well as newly recognized ones. Led by Dr. Krisztina Hanley and Dr. Gulisa Turashvilli from the CAP, this session covers how to spot these lesions and what to look for in biopsy and excision samples. Case-based examples will offer practical guidance. The link to register for both of these scientific courses offering CME credits is in the show notes. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in our CAP newsletters every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern. Subscribe to this show on Apple, Spotify, or your favorite podcast platform. I'm Nancy Johnson. Have a great day.

Share

Embed

You may also like

Transcription

  • Nancy Johnson

    AI tools are now treating patients around the clock. Where do physicians fit in? This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, August 18th. Here are the latest headlines. A medical center in LA is using AI to deliver 24-7 care to patients through an app. Cedars-Sinai found that AI treatment plan recommendations were considered optimal 77% of the time compared to 67% for plans by physicians. The CAP's Dr. Hung Luu says while AI shows promise, human physician expertise must remain central. especially when patient cases require clinical judgment beyond guidelines. He emphasizes that pathologists should train AI models directly to ensure treatment plans are always evidence-based. Read the full article in the show notes. In other news, pathologists can stay ahead in the rapidly evolving DEIA landscape with a new course at CAP25 next month in Orlando. This CME accredited session. will cover the latest regulations and describe current strategies to advance equity and improve patient care. Attendees will learn how shifting diversity, equity, inclusion, and accessibility priorities affect lab operations. Dr. Kisha Mitchell Richards, who chairs the CAP's DEI committee, will lead the session. Go to the show notes to register for CAP25. Also at CAP25, pathologists can sharpen their skills with a specialized course on pancreatic fine needle biopsies. Led by the CAP's Dr. Min Cui and Dr. Wei Xin, the session will tackle the diagnostic challenges presented by these tests. Through real-life cases, the course will explore both common and rare pancreatic lesions, including epithelial and metastatic tumors. It's designed for pathologists at all levels who interpret these complex biopsy samples. And finally, another course at the annual meeting will help pathologists better understand both common cervical glandular lesions as well as newly recognized ones. Led by Dr. Krisztina Hanley and Dr. Gulisa Turashvilli from the CAP, this session covers how to spot these lesions and what to look for in biopsy and excision samples. Case-based examples will offer practical guidance. The link to register for both of these scientific courses offering CME credits is in the show notes. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in our CAP newsletters every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern. Subscribe to this show on Apple, Spotify, or your favorite podcast platform. I'm Nancy Johnson. Have a great day.

Transcription

  • Nancy Johnson

    AI tools are now treating patients around the clock. Where do physicians fit in? This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, August 18th. Here are the latest headlines. A medical center in LA is using AI to deliver 24-7 care to patients through an app. Cedars-Sinai found that AI treatment plan recommendations were considered optimal 77% of the time compared to 67% for plans by physicians. The CAP's Dr. Hung Luu says while AI shows promise, human physician expertise must remain central. especially when patient cases require clinical judgment beyond guidelines. He emphasizes that pathologists should train AI models directly to ensure treatment plans are always evidence-based. Read the full article in the show notes. In other news, pathologists can stay ahead in the rapidly evolving DEIA landscape with a new course at CAP25 next month in Orlando. This CME accredited session. will cover the latest regulations and describe current strategies to advance equity and improve patient care. Attendees will learn how shifting diversity, equity, inclusion, and accessibility priorities affect lab operations. Dr. Kisha Mitchell Richards, who chairs the CAP's DEI committee, will lead the session. Go to the show notes to register for CAP25. Also at CAP25, pathologists can sharpen their skills with a specialized course on pancreatic fine needle biopsies. Led by the CAP's Dr. Min Cui and Dr. Wei Xin, the session will tackle the diagnostic challenges presented by these tests. Through real-life cases, the course will explore both common and rare pancreatic lesions, including epithelial and metastatic tumors. It's designed for pathologists at all levels who interpret these complex biopsy samples. And finally, another course at the annual meeting will help pathologists better understand both common cervical glandular lesions as well as newly recognized ones. Led by Dr. Krisztina Hanley and Dr. Gulisa Turashvilli from the CAP, this session covers how to spot these lesions and what to look for in biopsy and excision samples. Case-based examples will offer practical guidance. The link to register for both of these scientific courses offering CME credits is in the show notes. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in our CAP newsletters every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern. Subscribe to this show on Apple, Spotify, or your favorite podcast platform. I'm Nancy Johnson. Have a great day.

Share

Embed

You may also like

undefined cover
undefined cover